611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
Many U.S. Seniors May Need Better Knee Arthritis CareAfter COVID, Many Americans Are Struck by New Maladies: StudyCataracts: Common, and Easy to TreatThere Are Many Good Reasons for Kids to Get the COVID VaccineBabies Produce Strong Immune Response to Ward Off COVID-19: StudyNovavax's COVID Vaccine Shines in Latest TrialAHA News: U.S. Appears to Lose Ground in Controlling High Blood PressureOdds for Death, Hospital Care Rise When Statins Are StoppedWeight-Loss Surgeries Used Least in U.S. States That Need Them MostObesity Could Raise Odds for 'Long-Haul' COVID SymptomsSmokers, Obese People Need Major Heart Interventions Earlier in LifeOld Age No Bar to Successful Heart Transplant, Study FindsCOVID Antibody Treatment Is Safe, Effective in Transplant PatientsThere Is No 'Healthy Obesity,' Study FindsExpiration Dates on Johnson & Johnson COVID Vaccine ExtendedWill People Really Need a Yearly COVID Booster Vaccine?America Is Losing the War Against DiabetesGene Editing Technique Corrects Sickle Cell Disease in MiceCOVID Vaccines Appear Safe for People With IBDNew Treatment Fights Rare Cases of Vaccine-Linked Blood ClotsWoman Dies From Dengue Fever Acquired in FloridaAstraZeneca COVID Vaccine Tied to Rare Cases of Low Blood PlateletsWhy a COVID Diagnosis Could Cost You Way More Money in 2021New Links Between Poor Sleep, Diabetes and DeathVaccinations More Urgent as Variant That Crippled India Shows Up in the U.S.Think You Can Skip That Annual Physical?  Think AgainReal-World Study Shows Power of Pfizer, Moderna Vaccines to Prevent COVIDDeath Rates Are Rising Across Rural AmericaWhat Diet Is Most Likely to Help Ease Crohn's Disease?'Breakthrough' COVID Infections May Be Common in Vaccinated Transplant PatientsYour Teen's Smartphone Could Be Key to Unhealthy WeightToo Much Caffeine Might Raise Your Odds for GlaucomaPeople of Color Have Twice the Risk of Dying After Brain Injury, Study FindsStudy Pinpoints Cancer Patients at Highest Risk From COVIDMany Existing Drugs Could Be Potent COVID Fighters: StudyAntibiotics Won't Help Fight Lung-Scarring Disease IDF: StudyNew Disabilities Plague Half of COVID Survivors After Hospital DischargeDeclining Vaccination Rates Threaten Biden's July 4 GoalYour Doctor Appointments Might Look Different Post-PandemicPrior COVID Infection May Shield You From Another for at Least 10 MonthsTeens: You Got Your COVID Vaccine, What Now?White House Lists Countries Getting First Batch of Extra COVID VaccinesStrokes Hitting COVID Patients Are More Severe: StudyAverage COVID Hospital Bill for U.S. Seniors Nearly $22,000Deep Brain Stimulation Therapy May Help Parkinson's Patients Long TermNIH Starts Trial Assessing 'Mix & Match' COVID Vaccine ApproachAllergy Treatment Crucial If Your Child Has AsthmaScientists Discover Rare Form of ALS That Can Strike KidsGlobal Warming to Blame for 1 in 3 Heat-Related Deaths WorldwideBlood Sugar Tests Using Sweat, Not Blood? They Could Be on the Way
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Mixing COVID Vaccines Might Raise Odds for Minor Reactions: Study

HealthDay News
by By Steven Reinberg HealthDay Reporter
Updated: May 13th 2021

new article illustration

THURSDAY, May 13, 2021 (HealthDay News) -- Mixing the various COVID-19 vaccines -- for example, getting a first dose of the Pfizer vaccine but having your second dose be the AstraZeneca shot -- seems to increase the risk of side effects, a new study from Britain suggests.

Preliminary data from a study of 850 U.K. patients aged 50 and older that compared mixed dosing schedules of the Pfizer and AstraZeneca vaccines found an increase in the frequency of mild to moderate symptoms in people receiving mixed doses. The AstraZeneca vaccine is not available in the United States.

The adverse reactions didn't last long and there were no other safety concerns, the researchers stressed. In areas where the supply of one vaccine is limited, experts have wondered if the "mix-n-match" approach might work.

"Whilst this is a secondary part of what we are trying to explore through these studies, it is important that we inform people about these data, especially as these mixed-doses schedules are being considered in several countries," said researcher Matthew Snape, an associate professor in pediatrics and vaccinology at the University of Oxford.

"The results from this study suggest that mixed dose schedules could result in an increase in work absences the day after immunization, and this is important to consider when planning immunization of health care workers," he said in a university news release.

"Importantly, there are no safety concerns or signals, and this does not tell us if the immune response will be affected. We hope to report these data in the coming months. In the meantime, we have adapted the ongoing study to assess whether early and regular use of paracetamol [acetaminophen] reduces the frequency of these reactions," Snape said.

The researchers also said these data were from patients 50 and older, and it's possible these reactions may be more common in younger patients.

The trial is being done to see if mixing these vaccines might be an effective way of protecting people from COVID-19, especially if booster doses are needed.

In the study, four different combinations of prime and booster vaccination were given: a first dose of the AstraZeneca vaccine followed by boosting with either the Pfizer vaccine or a further dose of the AstraZeneca vaccine, or a first dose of the Pfizer vaccine followed by boosting with either the AstraZeneca vaccine or a second dose of the Pfizer vaccine.

In April, the researchers started to evaluate the Moderna and Novavax vaccines in a new U.K. study. (The Novavax vaccine is going through the approval process in the United States and Britain.) Volunteers received either the AstraZeneca or Pfizer vaccine, and were then randomly allocated to receive either the same vaccine for their second dose or a dose of the vaccines produced by Moderna or Novavax.

The report was published May 12 in the journal The Lancet.

More information

For more on COVID-19 vaccines, see the U.S. Centers for Disease Control and Prevention.

SOURCE: University of Oxford, news release, May 12, 2021